Back to User profile » Prof. Dr. Samuel Allemann
Papers published by Prof. Dr. Samuel Allemann:
Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters
Roth MM, Bencastro A, Meier CR, Huber CA, Meyer zu Schwabedissen HE, Allemann SS, Schneider C
Pharmacogenomics and Personalized Medicine 2026, 19:586384
Published Date: 20 May 2026
A Swiss Cross-Sectional Study on Patients’ Perspectives on Chronic Pain Management, Analgesic Treatment, and Genetic Susceptibility
Bollinger A, Stäuble CK, Urdieux IO, Meyer zu Schwabedissen HE, Allemann SS
Journal of Pain Research 2025, 18:4575-4587
Published Date: 5 September 2025
The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data
Wittwer NL, Meier CR, Huber CA, Moser JD, Meyer zu Schwabedissen HE, Allemann SS, Schneider C
Pharmacogenomics and Personalized Medicine 2025, 18:197-208
Published Date: 23 August 2025
Generative AI/LLMs for Plain Language Medical Information for Patients, Caregivers and General Public: Opportunities, Risks and Ethics
Pal A, Wangmo T, Bharadia T, Ahmed-Richards M, Bhanderi MB, Kachhadiya R, Allemann SS, Elger BS
Patient Preference and Adherence 2025, 19:2227-2249
Published Date: 31 July 2025
Comprehensive Description of an Automated Drug Dispensing System Database
Wittwer NL, Meier CR, Recknagel MJ, Allemann S, Schneider C
Pragmatic and Observational Research 2025, 16:129-134
Published Date: 8 April 2025
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
Bollinger A, Stäuble CK, Jeiziner C, Wiss FM, Hersberger KE, Lampert ML, Meyer zu Schwabedissen HE, Allemann SS
Pharmacogenomics and Personalized Medicine 2023, 16:693-706
Published Date: 3 July 2023
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
Wittwer NL, Meier CR, Huber CA, Meyer zu Schwabedissen HE, Allemann S, Schneider C
Pharmacogenomics and Personalized Medicine 2022, 15:967-976
Published Date: 23 November 2022
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
Jeiziner C, Allemann SS, Hersberger KE, Meyer zu Schwabedissen HE
Pharmacogenomics and Personalized Medicine 2022, 15:465-475
Published Date: 9 May 2022
Patient views on an electronic dispensing device for prepackaged polypharmacy: a qualitative assessment in an ambulatory setting
Allemann SS, Hersberger KE, Arnet I
Integrated Pharmacy Research and Practice 2015, 4:167-174
Published Date: 6 November 2015